Generalizability of Treatment Outcome Prediction Across Antidepressant Treatment Trials in Depression

被引:0
作者
Zhukovsky, Peter [1 ]
Trivedi, Madhukar H. [2 ]
Weissman, Myrna [3 ,4 ]
Parsey, Ramin [5 ]
Kennedy, Sidney [6 ,7 ]
Pizzagalli, Diego A. [1 ]
机构
[1] Harvard Med Sch, McLean Hosp, Ctr Depress Anxiety & Stress Res, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA
[2] Univ Texas Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA
[3] New York State Psychiat Inst & Hosp, Dept Psychiat, New York, NY USA
[4] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA
[5] SUNY Stony Brook, Dept Psychol, Stony Brook, NY USA
[6] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[7] Unity Hlth Toronto, Ctr Depress & Suicide Studies, Toronto, ON, Canada
关键词
EMOTION; SCALE; CARE;
D O I
10.1001/jamanetworkopen.2025.1310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Although several predictive models for response to antidepressant treatment have emerged on the basis of individual clinical trials, it is unclear whether such models generalize to different clinical and geographical contexts. Objective To assess whether neuroimaging and clinical features predict response to sertraline and escitalopram in patients with major depressive disorder (MDD) across 2 multisite studies using machine learning and to predict change in depression severity in 2 independent studies. Design, Setting, and Participants This prognostic study included structural and functional resting-state magnetic resonance imaging and clinical and demographic data from the Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) randomized clinical trial (RCT), which administered sertraline (in stage 1 and stage 2) and placebo, and the Canadian Biomarker Integration Network in Depression (CANBIND-1) RCT, which administered escitalopram. EMBARC recruited participants with MDD (aged 18-65 years) at 4 academic sites across the US between August 2011 and December 2015. CANBIND-1 recruited participants with MDD from 6 outpatient centers across Canada between August 2013 and December 2016. Data were analyzed from October 2023 to May 2024. Main Outcomes and Measures Prediction performance for treatment response was assessed using balanced classification accuracy and area under the curve (AUC). In secondary analyses, prediction performance was assessed using observed vs predicted correlations between change in depression severity. Results In 363 adult patients (225 from EMBARC and 138 from CANBIND-1; mean [SD] age, 36.6 [13.1] years; 235 women [64.7%]), the best-performing models using pretreatment clinical features and functional connectivity of the dorsal anterior cingulate had moderate cross-trial generalizability for antidepressant treatment (trained on CANBIND-1 and tested on EMBARC, AUC = 0.62 for stage 1 and AUC = 0.67 for stage 2; trained on EMBARC stage 1 and tested on CANBIND-1, AUC = 0.66). The addition of neuroimaging features improved the prediction performance of antidepressant response compared with clinical features only. The use of early-treatment (week 2) instead of pretreatment depression severity scores resulted in the best generalization performance, comparable to within-trial performance. Multivariate regressions showed substantial cross-trial generalizability in change in depression severity (predicted vs observed r ranging from 0.31 to 0.39). Conclusions and RelevanceIn this prognostic study of depression outcomes, models predicting response to antidepressants show substantial generalizability across different RCTs of adult MDD.
引用
收藏
页数:12
相关论文
共 37 条
  • [1] Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse
    Ang, Yuen-Siang
    Kaiser, Roselinde
    Deckersbach, Thilo
    Almeida, Jorge
    Phillips, Mary L.
    Chase, Henry W.
    Webb, Christian A.
    Parsey, Ramin
    Fava, Maurizio
    McGrath, Patrick
    Weissman, Myrna
    Adams, Phil
    Deldin, Patricia
    Oquendo, Maria A.
    McInnis, Melvin G.
    Carmody, Thomas
    Bruder, Gerard
    Cooper, Crystal M.
    Fatt, Cherise R. Chin
    Trivedi, Madhukar H.
    Pizzagalli, Diego A.
    [J]. BIOLOGICAL PSYCHIATRY, 2020, 88 (08) : 657 - 667
  • [2] Toward Best Practices for Imaging Transcriptomics of the Human Brain
    Arnatkeviciute, Aurina
    Markello, Ross D.
    Fulcher, Ben D.
    Misic, Bratislav
    Fornito, Alex
    [J]. BIOLOGICAL PSYCHIATRY, 2023, 93 (05) : 391 - 404
  • [3] Imaging Transcriptomics of Brain Disorders
    Arnatkeviciute, Aurina
    Fulcher, Ben D.
    Bellgrove, Mark A.
    Fornito, Alex
    [J]. BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2022, 2 (04): : 319 - 331
  • [4] Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics
    Buch, Amanda M.
    Liston, Conor
    [J]. NEUROPSYCHOPHARMACOLOGY, 2021, 46 (01) : 156 - 175
  • [5] The Montgomery Asberg and the Hamilton ratings of depression: A comparison of measures
    Carmody, Thomas J.
    Rush, A. John
    Bernstein, Ira
    Warden, Diane
    Brannan, Stephen
    Burnham, Daniel
    Woo, Ada
    Trivedi, Madhukar H.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 (08) : 601 - 611
  • [6] Illusory generalizability of clinical prediction models
    Chekroud, Adam M.
    Hawrilenko, Matt
    Loho, Hieronimus
    Bondar, Julia
    Gueorguieva, Ralitza
    Hasan, Alkomiet
    Kambeitz, Joseph
    Corlett, Philip R.
    Koutsouleris, Nikolaos
    Krumholz, Harlan M.
    Krystal, John H.
    Paulus, Martin
    [J]. SCIENCE, 2024, 383 (6679) : 164 - 167
  • [7] Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
    Cole, Eleanor J.
    Stimpson, Katy H.
    Bentzley, Brandon S.
    Gulser, Merve
    Cherian, Kirsten
    Tischler, Claudia
    Nejad, Romina
    Pankow, Heather
    Choi, Elizabeth
    Aaron, Haley
    Espil, Flint M.
    Pannu, Jaspreet
    Xiao, Xiaoqian
    Duvio, Dalton
    Solvason, Hugh B.
    Hawkins, Jessica
    Guerra, Austin
    Jo, Booil
    Raj, Kristin S.
    Phillips, Angela L.
    Barmak, Fahim
    Bishop, James H.
    Coetzee, John P.
    DeBattista, Charles
    Keller, Jennifer
    Schatzberg, Alan F.
    Sudheimer, Keith D.
    Williams, Nolan R.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2020, 177 (08) : 716 - 726
  • [8] Exceeding chance level by chance: The caveat of theoretical chance levels in brain signal classification and statistical assessment of decoding accuracy
    Combrisson, Etienne
    Jerbi, Karim
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2015, 250 : 126 - 136
  • [9] MRI predictors of pharmacotherapy response in major depressive disorder
    Gerlach, Andrew R.
    Karim, Helmet T.
    Pecina, Marta
    Ajilore, Olusola
    Taylor, Warren D.
    Butters, Meryl A.
    Andreescu, Carmen
    [J]. NEUROIMAGE-CLINICAL, 2022, 36
  • [10] A multi-modal parcellation of human cerebral cortex
    Glasser, Matthew F.
    Coalson, Timothy S.
    Robinson, Emma C.
    Hacker, Carl D.
    Harwell, John
    Yacoub, Essa
    Ugurbil, Kamil
    Andersson, Jesper
    Beckmann, Christian F.
    Jenkinson, Mark
    Smith, Stephen M.
    Van Essen, David C.
    [J]. NATURE, 2016, 536 (7615) : 171 - +